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Abstract   
Introduction:  Overviews are a new approach to summarising evidence and synthesising results from 
related systematic reviews. 
Objectives:  To conduct an overview of Cochrane systematic reviews to provide a contemporary 
review of the evidence for cardiac rehabilitation (CR), identify opportunities for merging or splitting 
existing Cochrane reviews, and identify current evidence gaps to inform new review titles. 
Methods: The Cochrane Database of Systematic Reviews was searched to identify reviews that 
address the objectives of this overview. Data presentation is descriptive with tabular presentations 
of review- and trial-level characteristics and results.  
Results: The six included Cochrane systematic reviews were of high methodological quality and 
included 148 randomised controlled trials in 97,486 participants. Compared to usual care alone, 
exercise-based CR reduces hospital admissions and improves patient health related quality of life 
(HRQL) in low to moderate risk heart failure and coronary heart disease (CHD) patients.  At 12 
months or more follow-up, there was evidence of some reduction in mortality in patients with CHD.  
Psychological- and education-based interventions appear to have little impact on mortality or 
morbidity but may improve HRQL. Home- and centre-based programmes are equally effective in 
improving HRQL at similar costs. Selected interventions can increase the uptake of CR programmes 
but evidence to support interventions that improve adherence is weak. 
Conclusions: This overview confirms that exercise-based CR is effective and safe in the management 
of clinically stable heart failure and post-MI and PCI patients. We discuss the implications of this 
overview on the future direction of the Cochrane CR reviews portfolio.  
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Funding: This study has no external funding. LJA is a University of Exeter Medical School funded 
Cochrane review Research Fellow.  
Highlights: 
 This overview provides a contemporary review of the evidence for cardiac rehabilitation, 
summarising the findings of six Cochrane systematic reviews of a total of 148 randomised 
controlled trials in 97,486 participants.  
 We conclude that exercise-based cardiac rehabilitation is an effective and safe therapy to be 
used in the management of clinically stable patients following myocardial infarction or 
percutaneous coronary intervention or who have heart failure.  
 A number of recommendations for the design and conduct of future RCTs and systematic 
reviews of cardiac rehabilitation are presented. 
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1. Introduction 
Cardiac rehabilitation (CR) can be defined as “The coordinated sum of activities required to influence 
favourably the underlying cause of cardiovascular disease, as well as to provide the best possible 
physical, mental and social conditions, so that the patients may, by their own efforts, preserve or 
resume optimal functioning in their community and through improved health behaviour, slow or 
reverse progression of disease” [1].  
The gold standard level of evidence to inform clinical and policy decisions on the use of new and 
existing therapeutic interventions is the systematic review of randomised controlled trials (RCTs), 
which can include a meta-analysis. The largest single producer of systematic reviews in health care is 
the Cochrane Collaboration, with more than 8400 published at the time of writing. Compared with 
systematic reviews published in paper-based journals, studies have consistently shown Cochrane 
systematic reviews to have greater methodological quality [2-4]. In the first two systematic reviews 
and meta-analyses of CR published more than 20 years ago, Oldridge and O’Connor reported a 20-
25% reduction in all-cause and cardiovascular mortality, pooling data from ten and 22 RCTs 
respectively, comparing rehabilitation and control in over 4,300 post-myocardial infarction patients 
[5, 6]. In 2001, Jolliffe et al published the first Cochrane review of exercise-based CR, updating the 
evidence to 32 RCTs in 8,440 post-myocardial infarction and revascularisation patients, and 
confirming a similar 27% mortality benefit of exercise-based CR [7].  
With funding support of the National Institute of Health Research (NIHR) in the United Kingdom, 
over the last 10 years the portfolio of published cardiac rehabilitation Cochrane reviews has grown 
to six systematic reviews/meta-analyses: Exercise-based rehabilitation for heart failure [8] ; Home‐
based versus centre‐based cardiac rehabilitation [9]; Exercise‐based cardiac rehabilitation for 
coronary heart disease [10]; Psychological interventions for coronary heart disease [11]; Patient 
education in the management of coronary heart disease [12] and Promoting patient uptake and 
adherence in cardiac rehabilitation [13]. The development of the portfolio of Cochrane reviews has 
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reflected many of the key areas of evolution in the provision of CR and how this model of service 
delivery can differ across international healthcare jurisdictions  These include, the shift from 
emphasis on exercise training alone to comprehensive secondary prevention, including risk factor 
and dietary education and management of psychological factors; the broadening of the population 
of patients receiving CR services to include those with heart failure; the development of alternative 
settings of CR delivery that include home provision in addition to the traditional supervised hospital 
or centre-based programmes and the need to focus the  outcomes of CR to inform the needs of 
healthcare policy makers (e.g. impacts on hospital admission, health-related quality of life (HRQL), 
and healthcare costs). The Cochrane CR review portfolio remains dynamic, with three reviews having 
undergone an update in the last 12-months [8, 9, 13]. 
Overviews of systematic reviews (overviews) are a new approach to summarising evidence, 
synthesising results from multiple systematic reviews into a single usable document [14]. By 
providing a single synthesis of all relevant evidence in a particular area, overviews may be useful for 
therapeutic and policy decision-making, providing a comprehensive ‘‘friendly front end’’ to the 
evidence, so that the reader does not have to assimilate data from separate systematic reviews. 
Overviews can also help inform the strategic direction of conduct and structuring of future 
systematic reviews. For example, the latest version of the Cochrane review of exercise-based CR for 
coronary heart disease (CHD) includes 47 RCTs in over 10,000 patients and may therefore benefit 
from being organised into sub-reviews (“splitting”) according to CHD indications i.e. post-MI, 
revascularisation and angina. Finally, overviews provide an opportunity to identify potential 
“evidence gaps” and therefore inform areas where new Cochrane reviews should be prioritised. 
This overview seeks to present a concise summary of the research question, methods and findings of 
the Cochrane reviews on CR. We also seek to identify the opportunities for merging or splitting 
across future Cochrane reviews, identify evidence gaps to inform de novo Cochrane CR review titles; 
and to provide recommendations to encourage uniformity of future reporting systematic reviews 
and RCTs of CR. While it is currently recognised that 'comprehensive' CR programmes should contain 
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exercise, education and psychological components, for clarity in this overview, we will pre-fix “CR” 
with the focus of the intervention where we feel it might help the reader in interpreting the 
evidence, e.g. exercise-based CR or education-based CR. 
 
2. Methods 
This overview was conducted in accordance with the recommendations for Cochrane overviews [14].  
2.1 Search methods for identification of reviews  
We initially included the six Cochrane CR reviews cited above [8-13]. In addition, we sought to 
include other Cochrane reviews that may inform the aims of this overview. 
The Cochrane Database of Systematic Reviews on The Cochrane Library (issue 4 of 12, April 2014) 
was searched using the search strategy listed in appendix A. No date or language restrictions were 
applied. Where reviews had been updated, only the most recent version was sought. We sought full 
cochrane reviews or protocols currently published in The Cochrane library of systematic reviews 
that: (1) examine the impact or delivery of CR; (2) include adults with heart disease, regardless of 
aetiology; and (3) include exercise training interventions either alone or in combination with an 
educational or psychological intervention or both, delivered in a hospital community or a home-
based setting.  
Two authors (LJA, RST) independently screened titles and abstracts from the searches and full-text 
articles were retrieved for all potentially includable full reviews or protocols. Any disagreements 
were resolved through discussion.  
2.2 Data extraction and management   
The following information was extracted from included Cochrane reviews: review 
objective/question, search time frame, inclusion criteria (study design, population, intervention, 
7 | P a g e  
 
comparator and outcomes), study limitations, source of funding, and stated conflicts of interest of 
review authors. The following outcome data were sought: (i) mortality: all cause and disease 
specific; (ii) morbidity:  fatal and non-fatal MI;  percutaneous coronary intervention (PCI); 
hospitalisation: overall and disease specific; (iii) HRQL assessed using validated instruments (e.g. SF-
36, EQ5D); (iv) measures of uptake of, or adherence to, CR; (v) costs and cost-effectiveness. 
We also extracted characteristics and outcome data for the RCTs included in each of the systematic 
reviews: number of included RCTs, year of publication, population, intervention and comparator, 
primary and secondary outcomes specified and collected, total duration of follow up, and number 
and location of study centres.   
Standardised data collection forms were used to extract characteristics of reviews and included 
studies. These forms were piloted on one review included in the overview. One author (LJA) 
extracted review and study characteristics from included reviews and a second author (RST) checked 
all extracted data for accuracy. If study level information within a published review was unclear or 
missing, we clarified this by reference to the published reports of the individual RCT. 
 
2.3 Assessment of methodological quality of reviews and included studies    
2.3.1 Quality of included Cochrane reviews  
A single reviewer (LJA) assessed the methodological quality of the included reviews using the 
‘Revised Assessment of Multiple Systematic Reviews’ (R-AMSTAR) measurement tool [15], where the 
11 domains of the original AMSTAR  tool [16] were scored between 1 and 4 and the R-AMSTAR total 
score ranged from 11 to 44. The assessment was checked by a second reviewer (RST). 
2.3.2 Quality of included RCTs 
We have reported the quality of included studies as reported in reviews using the Cochrane risk of 
bias tool.  The core risk of bias items include: the quality of random sequence generation and 
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allocation concealment, description of drop-outs and withdrawals, blinding of outcome assessment 
and presence of selective reporting [17]. We also assessed three further quality criteria: whether the 
study groups were balanced at baseline, if the study groups received comparable care (apart from 
the intervention), and whether an intention to treat analysis was undertaken. Where a risk of bias 
element was not reported within the review, the original included RCT publication was assessed by a 
single reviewer (LJA) and checked by a second reviewer (RST).  
2.4 Data presentation and synthesis   
The focus of the data presentation is descriptive with detailed tabular presentations of the extracted 
review and trial level information outlined above. We extracted review level summaries of the 
outcome findings detailed in each of the included reviews. No de novo data analysis of trial level 
outcomes was conducted for this overview. For each included review, we extracted all results for the 
outcomes listed above, and where outcomes were meta-analysed, we have reported pooled effect 
sizes.  Where no quantitative pooling of effect sizes has been reported, or where outcomes are 
reported descriptively by single studies, we have reported these results by vote counting [18] or 
using standardised language indicating direction of effect and statistical significance. For continuous 
outcomes, data is summarised using the standardised mean difference (SMD) or weighted mean 
difference (WMD) with 95% confidence interval (95% CI) as reported in the included reviews. For 
dichotomous outcomes, relative risk (RR) or odds ratio (OR) and 95% CI are presented as 
appropriate. Due to the heterogeneity of populations, interventions and outcomes in the included 
systematic reviews, we deemed it inappropriate to indirectly compare either CR interventions across 
reviews (e.g. exercise-training versus education for CHD) or to indirectly compare interventions 
across review populations (e.g. exercise training for CHD versus exercise training for HF).  This is in 
accord with the Cochrane Comparing Multiple Interventions Methods Group recommendations 
(http://cmimg.cochrane.org/methods-innovation-fund-stream-1) [19]. 
3. Results   
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3.1 Identification of reviews  
The review selection process is summarised in the flow diagram in Figure 1. Our database search 
yielded 91 titles from which we identified one published Cochrane review (in addition to the 
previously identified six reviews) and three Cochrane review protocols which were judged to meet 
the inclusion criteria.  On review of the full text we excluded the published Cochrane review [20] as 
while it evaluated physical therapy with an exercise component for elective cardiac surgery patients, 
only one included RCT compared cardiorespiratory exercise training with a non-exercise control. All 
other included RCTs assessed inspiratory muscle training. The three Cochrane protocols were judged 
to meet the inclusion criteria and are listed in Appendix B. The remainder of this overview focuses 
on presenting the six Cochrane CR reviews.  
3.2 Description of included Cochrane reviews   
The characteristics of the six included Cochrane reviews and included RCTs are summarised in Tables 
1 and 2 respectively.  
All included reviews were published between 2011 and 2014, with searches conducted from the 
inception of the electronic databases to 2013. In all reviews, searches were limited to an RCT design 
and in three cases the inclusion was limited to RCTs with follow up of 6 months or longer [8, 10, 12]. 
In total, the included reviews contained 148 RCTs and 97,486 participants. Four RCTs were included 
in more than one review [21-24]. The majority of included RCTs were published in the last two 
decades (1970-9: 4 RCTs; 1980-9: 16 RCTs; 1990-9: 40 RCTs; 2000-9: 72 RCTs, 2010 and later: 16 
RCTs). The median sample size of RCTs ranged widely from only 16 participants [25] to 46,606 
participants [26]. The majority of RCTs were undertaken either in Europe (69%) or North America 
(35%) and were mainly single centre (79%).  
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3.2.1 Search methods 
All six reviews searched Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, 
MEDLINE In-Process, EMBASE, CINAHL, and PsycINFO. Three reviews also undertook searches for 
ongoing RCTs using Trial registers (Controlled-trials.com and Clinicaltrials.gov) and all reviews 
searched for additional RCTs by manually checking the reference lists of included studies. 
3.2.2 Participants 
The types of participants included in this overview varied between reviews. The scope of two 
reviews included all adult heart disease patients, regardless of indication [9, 13], three reviews were 
limited to patients with coronary heart disease (post MI and PCI) [10-12] and one review was limited 
to heart failure [8].  Although 78% of the RCTs (which reported gender) included women, the median 
proportion of males included in RCTs ranged from 60 to 88% across reviews. The mean age of 
patients in RCTs ranged from 46 to 87 years.  
3.2.3 Interventions 
Two of the reviews included exercise training or exercise training alongside other interventions that 
included education or psychological support or both [8, 10]. One review focused on psychological 
interventions [11], although it included a number of RCTs that also incorporated an educational 
component. One review included only RCTs with an educational focus [12], one included 
interventions to increase the uptake and adherence to CR [13] and one compared the delivery of CR 
in home- and centre-based settings [9].  
3.2.4 Outcome measures 
All reviews pre-specified outcome measures that consistently included all-cause mortality and HRQL. 
Although all reviews sought morbidity outcomes, the definition and breadth of these outcomes 
varied across reviews. For example, the review by Heran et al stated that they sought MI (total, fatal, 
non-fatal), revascularisations (total, CABG, PTCA, stenting) and hospitalisations [10], while the 
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review by Karmali et al reported “CHD event rates” [13]. Four reviews sought economic outcomes 
[8-10, 12] and two reviews reported uptake or adherence data  [9, 13].  
3.2.5 Data analysis 
Five of the six reviews included meta-analyses of mortality and morbidity outcomes. The review by 
Karmali et al, pre-stated that heterogeneity (participants, interventions, and outcomes), together 
with the small number of studies identified, precluded undertaking meta-analysis [13]. Given the 
heterogeneity in measures, only one review used meta-analysis to pool HRQL data across RCTs [8], 
the other reviews using a descriptive and vote counting approach to summarise outcomes. This was 
also the case for uptake and adherence and economic outcomes. Two of the reviews undertook 
meta-regression analyses to explore how the impact of interventions varied across patient and RCT 
characteristics [8, 10].  
3.2.6 Methodological quality of included reviews   
Based on our assessments using the R-AMSTAR tool, all included reviews scored between 35 and 41 
(out of a possible maximum of 44) and were deemed of high methodological quality (see Table 3). 
None of the reviews stated that journals were hand-, or manually-searched and only one stated that 
searches were supplemented by consulting books or experts in the field.  Two reviews were marked 
down based on inadequate reporting of the publication status of their included studies. None of the 
reviews rated the quality of evidence based on a characterised instrument such as GRADE, and while 
all reviews used the Cochrane risk of bias tool, most were marked down as they failed to refer to the 
quality of included studies in formulating recommendations. The two weaknesses identified across 
reviews by R-AMSTAR were the lack of an explicit statement on the impact of findings on clinical 
practice guidelines and the failure to assess the sources of support or conflict of interest in the 
included RCTs.  
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3.2.7 Risk of bias of included RCTs 
All six Cochrane reviews used the core items of the Cochrane risk of bias tool (see Table 4). A 
consistent finding across reviews was that the included RCTs often failed to give enough detail to 
assess the adequacy of their potential risk of bias. Where details were reported, the quality of RCTs 
appeared to vary considerably across the risk of bias items.  Across all reviews, only a minority of 
RCTs were judged to be ‘adequate’ in terms of sequence generation (31%); sequence concealment 
(29%) and outcome blinding (24%).  Other aspects of RCT quality (baseline balance, selective 
reporting, loss of follow up, intention to treat analysis and groups receiving same intervention) were 
judged to be better (> 50% of all included RCTs achieving adequacy).  
3.3 Effect of interventions 
The outcome results across included Cochrane reviews are summarised in Table 5. 
3.3.1 Exercise-based cardiac rehabilitation for coronary heart disease [10] 
This review undertook database searches up to December 2009 with the inclusion of RCTs with 6 or 
more months follow up comparing exercise-based CR to no exercise control. A total of 47 RCTs were 
included across 10,794 patients who were mainly post-MI or PCI, predominantly male (median 88%) 
and with a median mean age of 55.0 years (see Table 2). The exercise-based CR programmes 
differed considerably across RCTs in duration (range 1 to 30 months), frequency (1 to 7 
sessions/week), and session length (20 to 90 minutes/session).  
Up to 12-month follow up, there was a trend towards a reduction in total mortality (relative risk (RR) 
0.82; 95% CI, 0.67 to 1.01) while no difference was seen between groups in cardiovascular mortality 
(RR 0.93; 95% CI, 0.71 to 1.21). At 12 or more months follow-up, exercise-based CR reduced overall 
(RR 0.87; 95% CI, 0.75 to 0.99) and cardiovascular mortality (RR 0.74; 95% CI, 0.63 to 0.87).  There 
was no evidence of a difference in risk of reinfarcton or PCI between the exercise-based CR and 
control groups. Ten of the included studies (2,379 participants) reported hospital admissions. In the 
shorter term (< 12 months follow-up) hospital admissions were also reduced compared to control 
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(RR 0.69; 95% CI, 0.51 to 0.93) but no evidence of a reduction in the longer term (> 12 months 
follow-up) was found (RR 0.98; 95% CI, 0.87 to 1.11). No evidence of heterogeneity of effect across 
RCTs was found for any of the mortality or morbidity outcomes. Univariate meta-regression showed 
no differences in intervention effects across various patient and RCT characteristics in mortality or 
morbidity outcomes. In seven out of 10 RCTs there was evidence of a significantly higher level of 
HRQL with exercise-based CR than control. Three of the included studies reported data on patient 
costs, but direct comparison was limited by differences in currencies and the time when the studies 
were conducted. 
 
3.3.2 Exercise-based rehabilitation for heart failure [8] 
This review was recently updated with searches up to March 2013 and included 33 RCTs with 6 or 
more months follow up, comparing exercise-based CR to no exercise control in 4,676 patients with 
heart failure. Patients were predominantly male (median 80%) with a median mean age of 60.5 
years, had a reduced ejection fraction (HFREF< 40-45%) and New York Heart Association 
classification I to III (see Table 2). The dose of exercise training ranged widely across RCTs from a 
session duration of 15 to 120 minutes, for one to seven sessions/week, and intensity an of 40 to 80% 
of maximal heart rate (or equivalent) over a period of one to 120 months.   
There was no evidence of difference in pooled mortality between intervention and controls at up to 
12 month follow-up (RR 0.93; 95% CI, 0.69 to 1.27). However, in the six RCTs with more than 12 
months follow-up, a trend towards a reduction in all-cause mortality with exercise was seen (RR 
0.88; 95% CI, 0.75 to 1.02). Compared to control, exercise training reduced the risk of overall (RR 
0.75; 95% CI, 0.62 to 0.92) and heart failure-specific hospitalisation (RR 0.61; 95% CI, 0.46 to 0.80) 
although there was no difference in all hospital admissions beyond 12 month follow-up (RR 0.92, 
95% CI, 0.66 to 1.29).  Exercise resulted in a clinically important improvement in the Minnesota 
Living with Heart Failure (MLHF) questionnaire (WMD: -5.8 points, -9.2 to -2.4) although there was 
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evidence of high levels of statistical heterogeneity (I2 = 70%). Univariate meta-regression analysis 
showed that these benefits in hospitalisation and HRQL were independent of patient characteristics, 
type and dose of CR, length of follow up, overall risk of bias, or RCT publication date. There was 
limited evidence to support CR for patients with heart failure with preserved ejection fraction 
(HFPEF; 3 RCTs, undefined participant number) and when exclusively delivered in a home-based 
setting (5 RCTs, 521 participants).   
Three RCTs reported economic data. Although no group differences in costs or outcomes across 
these three studies achieved statistical significance, two studies indicated exercise-based CR to be 
cost-effective (US$ 1773 per life-year saved [27] and a mean gain in QALY of 0.03 at an additional 
mean cost of US$ 1161 per person [28]). 
 
3.3.3 Psychological interventions for coronary heart disease [11] 
This review undertook searches up to January 2009 with the inclusion of RCTs of psychological 
interventions compared to usual care in patients with a diagnosis of coronary artery disease. A total 
of 24 RCTs were included in 9,087 patients who were predominantly low risk post-MI or PCI, male 
(median 84%) with a median mean age of 57 years (see Table 2). The review authors reported 
substantial variability in the intensity of treatments offered across RCTs; the mean number of hours 
spent in treatment was 26.1 (2.4 hrs to 96 hrs). 
The majority of the interventions were based on group therapy sessions or comprised a mix of group 
and individual session; only four RCTs used treatments that were delivered only on an individual 
basis. There was evidence of a trend towards a reduction in all-cause mortality (RR 0.89; 95% CI, 0.75 
to 1.05) and fewer cardiac deaths with psychological intervention (RR 0.80; 95% CI 0.64 to 1.00). 
There were significant effects on occurrence of revascularisation (RR 0.95; 95% CI 0.80 to 1.13) and 
non-fatal reinfarction (RR 0.87; CI 0.67 to 1.13). One of seven studies reported superiority in HRQL 
with psychological intervention compared to usual care. 
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3.3.4 Patient education in the management of coronary heart disease [12] 
This review undertook searches up to August 2010 with the inclusion of RCTs with follow up of 6 
months or more, of patient education interventions compared to usual care. A total of 13 RCTs were 
included across 68,649 participants with heart failure, stable angina, and post-MI or PCI who were 
predominantly male (median 60%) with a median mean age of 62.0 years (see Table 2). 
Interventions varied considerably across RCTs, with some providing group sessions, some 
individualised education and others both.  Educational ’dose’ ranged from a total of two clinic visits 
to a four-week residential stay with 11 months of follow-up sessions. There was no evidence of a 
significant difference in total mortality (RR 0.79; 95% CI, 0.55 to 1.13) or morbidity. Across the 
eleven RCTs which reported HRQL, whilst there was no consistent difference in HRQL total or 
domain score at follow-up between intervention and control, five RCTs demonstrated statistically 
significant differences in some domains in favour of intervention.  Five RCTs reported healthcare 
utilisation and costs. 
 
3.3.5 Home-based versus centre-based cardiac rehabilitation [13] 
This review was recently updated with searches up to November 2012 and sought to include RCTs 
comparing home-based and centre-based CR. Home-based CR was defined as ‘a structured 
programme with clear objectives for the participants, including monitoring, follow up visits, letters 
or telephone calls from staff, or at least self-monitoring diaries’ and centre-based CR was defined as 
‘based in a variety of settings (e.g. hospital physiotherapy department, university gymnasium, 
community sports centre)’. A total of 17 RCTs were included in 2,266 patients with stable angina, 
heart failure and post-MI and PCI who were predominantly male (median 80%) with a median mean 
age of 60 years (see Table 2).  The majority of RCTs compared comprehensive programmes (i.e. 
exercise training plus education and/or psychological interventions) with the exercise components 
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differing considerably across RCTs in duration (range: 1.5 to 6 months), frequency (1 to 5 sessions 
per week) and session length (20 to 60 minutes per session).   
A pooled analysis found no evidence of a significant difference in mortality up to 12 months follow-
up between home and centre CR (RR 1.26; 95% CI, 0.68 to 2.33). Four studies reported cardiac 
events, but no pooling of data was possible due to differences in the varied nature of the reported 
events. There was no evidence of difference between the two settings in overall or domain HRQL 
scores in individual RCTs. Four out of the 14 studies reporting adherence found superior adherence 
in the home-based compared with centre-based CR setting. No consistent difference was seen in the 
healthcare costs of the two forms of CR. 
 
3.3.6 Promoting patient uptake and adherence in cardiac rehabilitation [13] 
This review was recently updated with searches up to January 2013 and sought to include RCTs of 
interventions to increase CR uptake (participants attendance or enrolment in CR programmes) or 
adherence (extent to which the participant’s behaviour concurred with the advice given by health 
professional, e.g. to attend CR meetings or to undertake independent exercise) . A total of 18 RCTs 
were included in 2,266 participants with heart failure, stable angina, and post-MI and PCI who were 
predominantly male (median 84%). Meta-analysis was not undertaken due to heterogeneity in 
outcome definition across RCTs. Of the ten RCTs (1,658 participants) evaluating the effectiveness of 
interventions to increase uptake of cardiac rehabilitation, eight reported higher rates of CR uptake in 
the intervention group (range 11% to 46%). Interventions which improved uptake of CR included: 
structured nurse or therapist-led contacts; early appointments after discharge; motivational letters; 
gender-specific programmes; and intermediate phase programs for elderly patients. Three out of 
eight RCTs (1,167 participants) found significant improvements in adherence to CR although there 
was no evidence of an improvement in HRQL. Interventions which improved adherence included 
self-monitoring of activity, action planning, and tailored counselling by CR staff. Although data was 
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limited, there was no evidence of a difference in mortality or morbidity with uptake or adherence 
interventions. No RCTs reported on costs or cost-effectiveness.  
 
4. Discussion   
4.1 Summary of main results 
CR programmes have become an integral part of the standard of care for patients with heart 
disease. The scope of contemporary CR has shifted from exercise interventions alone to more 
comprehensive secondary prevention programmes that include risk factor education and 
psychological support. This overview identified six Cochrane systematic reviews of RCTs that have 
assessed the outcomes of various aspects of the delivery of CR and its component interventions.  
The key outcome findings of our overview are: (i) Compared to a no exercise training control, 
exercise-based CR in low to moderate risk patients with heart failure and after MI or PCI is safe, with 
no increase in short-term mortality, and effective, in terms of reductions in the risk of hospital 
admission and improvements in patient HRQL, as well as some evidence of a reduction in total and 
cardiovascular mortality in CHD patients at 12 months or more follow-up. Whilst there was 
considerable evidence of heterogeneity across included primary studies in both the characteristics of 
the evaluated CR programmes and also across the included patients, the outcome benefits of CR in 
terms of HRQL and reduced hospitalisation appeared to be independent of these programme and 
patient characteristics; (ii) Psychological-based and education-based interventions alone appear to 
have little or no impact on mortality or hospitalisation, but may improve HRQL of CHD patients in 
comparison with usual care alone; (iii) Home based and centre-based programmes seem to be 
equally effective in improving the outcomes of exercise-based CR in low risk patients after MI or 
post-revascularisation or with heart failure. Healthcare costs of the two forms of CR are similar, 
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presumably as any cost reduction in delivering the intervention in the home is offset by the 
associated costs of delivering individual nursing care; and  (iv) Uptake of CR programmes is only 
weakly supported by interventions designed to improve adherence to CR programmes.  
4.2 Strengths and limitations   
The included Cochrane systematic reviews were generally of high quality and three had been 
updated with a literature search within the past three years [8, 9, 13]. None of the reviews 
commented on the quality of the interventions or comparison groups described by the RCTs, 
although it is recognised that this would be restricted by limited reporting of the interventions in the 
RCTs. This limitation should be taken into consideration when interpreting the evidence presented.   
The quality of the primary RCTs in the included systematic reviews was variable. The main sources of 
bias in the primary studies were inadequate reporting of allocation concealment and randomisation 
methods and lack of outcome blinding. Another potential source of inconsistency which was not 
reported within reviews, was differential use of outcome data by RCTs i.e. some studies analysed 
only post interventional data while others measured pre-post change.  
There are a number of published non Cochrane systematic reviews of CR [29-33]. Given our focus 
was Cochrane review we acknowledge that this overview cannot be regarded as an all-inclusive 
summary of the evidence base for CR. However, by focusing on high quality Cochrane reviews, we 
believe this overview provides a least biased estimate of the impact of CR.  
This overview includes RCTs conducted between 1974 and 2013. During this time, there have been 
major advances in medical management, such as the increased use of statins since the mid-1990s.  
Indeed it has been hypothesised that major advances in post-MI medical management in the last 
decade has led to a reduction in the incremental effect on mortality of CR compared with usual care 
alone [34]. This decrement in mortality benefit of CR is supported by the rehabilitation after 
myocardial infarction (RAMIT) trial. This trial randomised 1,813 patients in 14 hospitals in England 
and Wales to receive either comprehensive CR or usual care and found no difference in all-cause 
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mortality at 2 years (RR 0.98, 95% CI 0.74 to 1.30) or after 7-9 years (0.99, 95% CI 0.85 to 1.15) [35]. 
This RCT was published after the search cut of the exercise-based CR for CHD Cochrane review.   
A potential strength of an overview is that it can provide an opportunity to undertake indirect 
comparisons across interventions that might not be included in single systematic reviews using 
mixed treatment comparisons and network meta-analysis methods [14, 36]. In brief, an indirect 
comparison involves the comparison of two (or more) interventions via one or more common 
comparator. For example, we may seek to compare the impact of exercise-based interventions and 
psychological-based interventions via the combination of RCTs of exercise-based intervention versus 
usual care with RCTs of psychological-based intervention versus usual care. However, for the 
intervention effect determined using an indirect comparison to be valid and equivalent to the 
intervention effect measured using a direct comparison, the sets of RCTs used to obtain the indirect 
comparison need to sufficiently similar in their characteristics i.e. patient population, intervention, 
comparator and outcomes across trials need to similar – the transitivity assumption [37]. Given the 
substantial heterogeneity in the populations of the included RCTs, not only between, but also within 
the included CR systematic reviews, we deemed indirect comparisons as inappropriate in the case of 
this overview. Based on the same reasoning, readers of this overview need to apply considerable 
caution in taking an informal indirect comparison approach and comparing the results for a given 
outcome across reviews.   
4.3 Agreements and disagreements with other overviews 
Oldridge recently undertook an overview of meta-analyses of CR [38]. Given that this overview 
included both Cochrane and non-Cochrane meta-analyses published since 2000, there is 
considerable overlap in findings and conclusions with the present overview. However, an important 
difference between the two overviews is the conclusion of a reduction in all-cause and 
cardiovascular mortality with CR in the review by Oldridge. This mortality benefit was primarily seen 
in the two non-Cochrane meta-analyses [30, 39], while the Cochrane review found a statistically 
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significant reduction in all-cause and cardiac mortality only at follow-up of greater than 12 months 
(Heran 2011).  
. 4.4 Implications for research   
The central aim of this overview was to inform conduct and direction of the Cochrane systematic 
reviews of CR. In brief, we make the following recommendations for future CR systematic reviews: 
(1) Scope of reviews: the scope of CR reviews needs to reflect current guidelines advising that CR 
should be based on an individually prescribed programme of exercise training with appropriate co-
intervention including psychological or educational interventions. 
(2) Handling clinical heterogeneity: a key challenge of CR systematic reviews is the substantive level 
of heterogeneity in the population and interventions across RCTs.  A number of approaches can be 
used to handle heterogeneity in future reviews, including stratification of outcome results by patient 
indication or intervention type (i.e. exercise training only versus comprehensive CR interventions); 
reporting within RCT subgroup analyses; and use of meta-regression to explore the impact of patient 
and intervention characteristics on outcomes between trials.  
(3) Effectiveness and costs of different CR interventions: broadening the inclusion criteria of reviews 
to include the active comparator arms of RCTs that allow comparisons of different CR interventions 
and consideration of the use of the indirect comparison methods [40].  
(4) Consistency in review conduct and reporting: to facilitate comparison across CR systematic 
reviews and the efficient future update of this overview, future Cochrane CR reviews need to 
standardise their conduct, including improved reporting of included RCT characteristics, content and 
quality/fidelity of delivery of interventions, and risk of bias assessment criteria, and outcomes.  
This overview also highlights several potential areas for consideration in the conduct of future RCTs 
of CR. RCT recruitment criteria need to better reflect the real world of CR delivery that includes 
patients at higher risk who are older, female and from a broader range of ethnicities and socio-
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economic groups. Reporting of trial methods should be improved (e.g. details of the process of 
randomisation and outcome blinding) and consistency is needed in the collection and reporting of 
outcome measures, including the use of validated HRQL, cardiac-related events, re-admissions and 
costs. Finally, as noted by Clark and colleagues, future RCTs need to better “open the black box” of 
CR [41]. In other words, to determine the incremental benefits of the various components of CR 
requires future RCTs to provide more precise descriptions of their CR interventions so these 
comparisons can more explicitly and reliably undertaken in future systematic reviews. A recent 
publication provides researchers and clinicians with a framework to improved reporting of 
intervention detail [42]. Also, future RCTs should be designed to provide a ‘head-to-head’ 
comparison of different combinations of CR interventions (e.g. an ‘exercise only’ CR intervention 
compared versus ‘exercise plus’ CR intervention). 
4.5 Implications for policy 
The evidence compiled by this overview support current international clinical guidelines which state 
that the addition of exercise-based CR to medical management is effective, (improving HRQL and 
reducing the risk of future hospitalisations) and safe (with no increase in short-term mortality), 
compared to a no exercise training control, for clinically stable patients following MI or PCI or who 
have heart failure [43-46]. Future RCTs of CR need to improve their reporting methods and better 
reflect the real world practice including the recruitment of higher risk patients and consideration of 
contemporary models of CR delivery, and identify effective interventions for enhancing adherence to 
rehabilitation.    
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Table 1. Summary of included Cochrane review characteristics  
Short title Review 
Reference 
 
Exercise for CHD  
Heran 2011 [10] 
Exercise for HF  
Taylor 2014a [8] 
Psychological for CHD 
Whalley 2011 [11] 
Education for CHD 
Brown 2011 [12] 
Home vs centre  
Taylor 2014b [9] 
Uptake & adherence 
Karmali 2014 [13] 
Main objective To determine the 
effectiveness of 
exercise-based CR 
(exercise training alone 
or in combination with 
psychosocial or 
educational 
interventions) on 
mortality, morbidity and 
health-related quality of 
life of patients with 
CHD. 
To determine the 
effectiveness of 
exercise-based 
interventions 
compared with usual 
medical care by 
focusing on the 
mortality, hospital 
admission rate, 
morbidity and health-
related quality of life in 
patients with heart 
failure. 
1. To determine the 
independent effects of 
psychological 
interventions in patients 
with CHD 
 
1. Assess effects of 
patient education on 
mortality, morbidity, 
HRQL and healthcare 
costs in patients with 
CHD. 
 
To determine the 
effectiveness of home-
based CR programmes 
compared with 
supervised centre-
based CR on mortality 
and morbidity, HRQL 
and modifiable cardiac 
risk factors in patients 
with CHD. 
To determine the effects, 
both harms and benefits, 
of interventions to 
increase patient uptake 
of, and adherence to, CR. 
Search time frame  Nov 2000 to Dec 2009 2008 to March 2013 2001 to Jan 2009 1990 to Aug 2010 2008 to Nov 2012 2008 to Jan 2013 
Study design RCTs (follow up ≥ 6 
months) 
RCTs (follow up ≥ 6 
months)  
RCTs  (no minimum 
follow up) 
RCTs (follow up ≥ 6 
months) 
RCTs (no minimum 
follow up)  
RCTs (no minimum follow 
up) 
Population 
 
 
 
 
 
 
 
 
 
 
Inclusion 
Post-MI 
Post revascularisation 
CHD defined by 
angiography 
 
Exclusion 
Heart valve surgery 
Heart failure  
Heart transplantation 
CRT ICD implant 
Inclusion 
Heart failure 
 
Inclusion 
Post-MI 
Post revascularisation 
Angina 
CHD defined by 
angiography 
 
Exclusion 
None 
Inclusion 
Post-MI 
Post revascularisation 
Angina 
CHD defined by 
angiography 
 
Exclusion 
Heart valve surgery 
Heart failure  
Heart transplantation 
CRT ICD implant. 
Inclusion 
Post-MI 
Post revascularisation 
Angina 
Heart failure 
 
Exclusion 
Heart valve surgery 
Heart failure  
Heart transplantation 
CRT ICD implant 
Inclusion 
Post-MI 
Post revascularisation 
Angina 
Heart failure  
CHD 
 
Exclusion 
Heart valve surgery 
Heart failure  
Heart transplantation 
CRT ICD implant 
Intervention Exercise training with or 
without the addition of 
psychosocial and/or 
educational 
interventions. 
Exercise training with 
or without the addition 
psychosocial and/or 
educational 
interventions. 
Psychological 
interventions delivered 
by health care workers 
with speciﬁc training in 
psychological techniques 
Patient education 
interventions involving 
direct contact with a 
health professional and 
including structured 
knowledge transfer 
about CHD. 
 CR programmes 
delivered in a home-
based setting  
CR, plus any intervention 
with the specific aim of 
increasing patient uptake 
of, or adherence to, CR or 
any of its component 
parts.  
Comparator No exercise training 
control that can include 
psychological and/or 
educational 
interventions or 
No exercise training 
control that can include 
psychological and/or 
educational 
interventions or 
No psychological 
intervention control that 
can include exercise 
interventions or 
standard medical care 
No education 
intervention control that 
can include exercise 
interventions or 
standard medical care 
CR programmes 
delivered in a centre-
based setting  
CR programmes without 
the intervention  
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standard medical care. standard medical care 
Outcomes  Mortality (total, CV, 
non CV) 
 MI (total, fatal, non-
fatal) 
 Revascularisations 
(total, CABG, PTCA, 
restenting) 
 Hospitalisations 
(total, CV, other)  
 HRQL 
 Economic: (costs and 
cost-effectiveness) 
 Mortality (total, HF 
and sudden death) 
 Hospitalisation 
(total, HF-related) 
 HRQL 
 Economic: (costs 
and cost-
effectiveness) 
 
 
 Mortality (total and 
CV)  
 Morbidity (Non-fatal 
MI) 
 Revascularisation 
(CABG and PTCA) 
 Psychological well-
being Anxiety, 
Depression, stress 
and Type A 
 Behaviour/hostility 
 HRQL 
 
 
 Mortality (total, CV 
and non CV) 
 Total CV events  
 MI  (fatal and/or 
non-fatal) 
 Other fatal and/or 
non-fatal CV 
events 
 Revascularisations 
(CABG, PTCA with or 
without stenting) 
 Hospitalisations 
(cardiac-related) 
 HRQL 
 Withdrawals/drop-
outs 
 Economic 
(Healthcare costs 
and cost-
effectiveness) 
 
 Mortality (total and 
CV) 
 Morbidity 
(reinfarction, 
revascularisation, 
cardiac associated 
hospitalisation)  
 Exercise capacity 
 Risk factors 
(smoking 
behaviour, blood 
lipid levels, blood 
pressure) 
 HRQL 
 Adverse events 
(withdrawal from 
the exercise 
programme), 
 Adherence to 
rehabilitation 
 Economic (health 
service use, costs 
and cost-
effectiveness) 
 
Uptake of, or adherence 
to, CR (primary) 
 Mortality (total) 
 Morbidity 
 Risk factors (smoking 
Behaviour, blood lipid 
levels, blood pressure) 
 HRQL,  
 Economic 
(Healthcare costs 
and cost-
effectiveness) 
 Any beneficial or 
adverse events  
CABG: coronary artery bypass grafting; PTCA: percutaneous transluminal coronary angioplasty; CAD: coronary artery disease; CV: cardiovascular; HRQL: health-related quality of life 
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Table 2. Summary of characteristics of included RCTs  
Short title Review 
Reference 
 
Exercise for CHD  
Heran 2011 [10] 
Exercise for HF  
Taylor 2014a [8] 
Psychological for CHD 
Whalley 2011 [11] 
Education for CHD 
Brown 2011 [12] 
Home vs centre  
Taylor 2014b [9] 
Uptake & adherence Karmali 
2014 [13] 
Number of RCTs (patients) 47 RCTs 
(10,794 patients) 
33 RCTs  
(4,740 patients) 
 
24 RCTs  
(9,296 patients) 
13 RCTs  
(68,556 patients) 
 
17 RCTs 
(2,172 patients) 
18 RCTs (2,505 patients) 
 
Nature of Intervention 
   Exercise only 
   Psychological only 
   Education only 
   >1 intervention 
 
17 
0 
0 
a29 
 
 
 
 
21 
0 
0 
12 
  
0 
14 
0 
10  (psych and 
education) 
 
0 
0 
13  
0 
 
6 
0 
0 
11 
Interventions aimed at 
increasing patient uptake of 
CR:  (10 RCTs) 
 
Interventions designed to 
increase adherence to 
exercise (7 RCTs) or 
supervised CR: (1 RCT) 
Sample size    
  median (range) 
142 (28 to 2304) 
 
54 (19 to 2331) 133 (44 to 2481) 288 (87 to 46,606) 104 (20 to 525) 110 (16 to 597) 
Intervention duration 
[months] 
Median (range) months 
3 (1 to 30) 6 (1 to120)  
 
NR 6 (1 to 30)  
 
3 (1.5 to 6)  
 
Not reported 
bPublication year 
   1970-9 
   1980-9 
   1990-9 
   2000-9 
   2010+ 
 
2 
11 
20 
14 
0 
 
0 
0 
5 
20 
8 
 
2 
4 
8 
10 
0 
 
0 
0 
4 
9 
0 
 
0 
1 
2 
11 
3 
 
0 
2 
3 
8 
5 
Percent male 
   Median (range) 
88 (0 to 100) 80 (36 to 100)  84 (0 to 100) 60 (0 to 100)   80 (60 to 100) 84 (0 to 100) 
Percent white 
   Median (range) 
NR N = 8 
85 (60 to 100) 
NR N=6 
86 (55 to 97)  
N=1 
80 
N = 6 
79 (43 to 95) 
Median Mean Age 
(range) 
55 (49 to 70) 
 
60 (51 to 81) 
 
57 (51 to 62) 
 
62 (51 to 73) 
 
60 (52 to 69) 
 
62 (51 to 77) 
 
bIndication 
MI only 
Angina only 
Revasc only 
MI and/or revasc 
MI or angina 
Mixed CHD  
HF 
dMean LVEF (%) (range) 
Includes NYHA IV 
[N(%)]Arrhythmia 
 
28 
1 
1 
4 
4 
9 
0 
 
 
0 
 
0 
0 
0 
0 
0 
0 
33 
29 (21-41) 
6 (18)0 
 
10 
1 
4 
4 
2 
2 
0 
 
 
1 
 
2 
1 
2 
1 
0 
4 
3 CHD or HF 
 
 
0 
 
4 
0 
4 
5 
0 
0 
3 
 
 
1 
 
4 
0 
0 
3 
3 
7 
1 
 
 
0 
26 | P a g e  
 
bStudy location 
   Europe 
   North America 
   Asia/Australia 
   Other 
Not Reported 
 
20 (43) 
3 (6) 
7 (15) 
- 
17 (36) 
 
20 (64) 
11 (30) 
1 (3) 
1 (3) 
0 
 
11 (46) 
11 (46) 
2 (8) 
0 
0 
 
7 (54) 
6 (46) 
0 
0 
0 
 
10 (58) 
5 (29) 
1 (6) 
1 (6) 
0 
 
6(33)  
11 (61) 
1(6) 
0 
0 
bSingle centre 23 (49) 30 (91) 8 (33) 4 (31) 15 (88) c10/16 (63) 
Follow up duration 
[months] 
Median (range) months 
24 (6 to 120)  6 (6 to 120)  NR 18 (6 to 60) 6 (2 to 72) 3 (1.5 to 12)  
a 1 RCT randomly assigned to exercise-only or comprehensive intervention 
bN RCTs (percent); 
cTwo studies were unavailable to us as they were unpublished degree dissertations. 
dSource, Sagar et al, 2014  [47] 
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Table 3.  R-AMSTAR assessment of included systematic reviews 
Short title  
Review Reference 
 
Exercise for CHD  
Heran 2011 [10] 
Exercise for HF  
Taylor 2014a 
[8] 
Psychological 
for CHD 
Whalley 2011 
[11] 
Education for 
CHD Brown 
2011 [12] 
Home vs 
centre  
Taylor 2014b 
[9] 
Uptake & 
adherence 
Karmali 2014 
[13] 
1. Was an ‘a priori’ design provided?  
(A) ‘a priori’ design 
(B) statement of inclusion criteria 
(C) PICO/PIPO research question (population, intervention, comparison, prediction, outcome) 
 
 
Yes  
Yes  
Yes 
4 
 
Yes  
Yes  
Yes 
4 
 
Yes  
Yes  
Yes 
4 
 
Yes  
Yes  
Yes 
4 
 
Yes  
Yes  
Yes 
4 
 
Yes  
Yes  
Yes 
4 
2. Was there duplicate study selection and data extraction? 
(A) There should be at least two independent data extractors as stated or implied. 
(B) Statement of recognition or awareness of consensus procedure for disagreements. 
(C) Disagreements among extractors resolved properly as stated or implied 
 
 
Yes 
Yes  
Yes  
4 
 
aYes   
Yes  
Yes  
4 
 
aYes 
Yes  
Yes 
4 
 
aYes  
Yes  
Yes 
4 
 
aYes  
Yes  
Yes  
4 
 
Yes 
Yes  
Yes    
4 
3. Was a comprehensive literature search performed? 
(A) At least two electronic sources should be searched. 
(B) The report must include years and databases used (e.g. Central, EMBASE, and MEDLINE). 
(C) Key words and/or MESH terms must be stated AND where feasible the search strategy outline should 
be provided such that one can trace the filtering process of the included articles. 
(D) In addition to the electronic databases (PubMed, EMBASE, Medline), all searches should be 
supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the 
particular field of study, and by reviewing the references in the studies found. 
(E) Journals were “hand-searched” or “manual searched” (i.e. identifying highly relevant journals and 
conducting a manual, page-by-page search of their entire contents looking for potentially eligible studies) 
 
 
Yes 
Yes 
Yes  
 
No  
 
 
No  
 
3 
 
Yes 
Yes 
Yes  
 
Yes  
 
 
No  
 
4 
 
Yes 
Yes 
Yes  
 
Yes   
 
 
No  
 
4 
 
Yes 
Yes 
Yes  
 
Yes  
 
 
No  
 
4 
 
Yes 
Yes 
Yes  
 
Yes  
 
 
No  
 
4 
 
Yes 
Yes 
Yes  
 
No  
 
 
No  
 
3 
4. Was the status of publication (i.e. grey literature) used as an inclusion criterion?  
(A) The authors should state that they searched for reports regardless of their publication type. 
(B) The authors should state whether or not they excluded any reports (from the systematic review), based 
on their publication status, language etc. 
(C) “Non-English papers were translated” or readers sufficiently trained in foreign language 
(D) No language restriction or recognition of non-English articles 
 
 
bNo  
Yes  
 
Yes  
Yes  
4 
 
bNo  
Yes  
 
No  
Yes  
3 
 
No  
Yes  
 
Yes  
Yes 
4 
 
bNo  
Yes  
 
Yes  
Yes 
4 
 
Yes  
Yes  
 
No   
Yes  
4 
 
bNo  
Yes  
 
No  
Yes 
3 
5. Was a list of studies (included and excluded) provided? 
(A) Table/list/or figure of included studies, a reference list does not suffice. 
(B) Table/list/figure of excluded studies, either in the article or in a supplemental source (i.e. online). 
(Excluded studies refers to those studies seriously considered on the basis of title and/or abstract, but 
rejected after reading the body of the text) 
(C) Author satisfactorily/sufficiently stated the reason for exclusion of the seriously considered studies. 
(D) Reader is able to retrace the included and the excluded studies anywhere in the article bibliography, 
reference, or supplemental source 
 
Yes 
Yes  
 
Yes  
Yes  
 
4 
 
Yes 
Yes  
 
Yes  
Yes  
 
4 
 
Yes 
Yes  
 
Yes  
Yes  
 
4 
 
Yes 
Yes  
 
Yes  
Yes 
 
4 
 
Yes 
Yes  
 
Yes  
Yes  
 
4 
 
Yes 
Yes  
 
Yes  
Yes 
 
4 
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6. Were the characteristics of the included studies provided? 
 (A) In an aggregated form such as a table, data from the original studies should be provided on the 
participants, interventions 
AND outcomes. 
(B) Provide the ranges of relevant characteristics in the studies analysed (e.g. age, race, sex, relevant 
socioeconomic data, disease status, duration, severity, or other diseases should be reported.) 
(C) The information provided appears to be complete and accurate (i.e. there is a tolerable range of 
subjectivity here. Is the reader left wondering? If so, state the needed information and the reasoning). 
 
 
 
Yes 
 
Yes  
 
Yes  
 
4 
 
 
Yes 
 
Yes  
 
Yes  
 
4 
 
 
Yes 
 
Yes  
 
Yes 
 
4 
 
 
Yes 
 
Yes  
 
Yes 
 
4 
 
 
Yes 
 
Yes  
 
Yes  
 
4 
 
 
Yes 
 
Yes  
 
Yes 
 
4 
7. Was the scientific quality of the included studies assessed and documented? 
(A) ‘A priori’ methods of assessment should be provided (e.g., for effectiveness studies if the author(s) 
chose to include only randomized, double-blind, placebo controlled studies, or allocation concealment as 
inclusion criteria); for other types of studies alternative items will be relevant. 
(B) The scientific quality of the included studies appears to be meaningful. 
(C) Discussion/recognition/awareness of level of evidence 
(D) Quality of evidence should be rated/ranked based on characterized instruments. (Characterized 
instrument is a created instrument that ranks the level of evidence, e.g. GRADE [Grading of 
Recommendations Assessment, Development and Evaluation.]) 
 
Yes 
 
 
Yes  
Yes  
No  
 
3 
 
Yes 
 
 
Yes  
Yes  
No  
 
3 
 
Yes 
 
 
Yes  
Yes  
No 
 
3 
 
Yes 
 
 
Yes  
Yes  
No 
 
3 
 
Yes 
 
 
Yes  
Yes  
No  
 
3 
 
Yes 
 
 
Yes  
Yes  
No 
 
3 
8. Was the scientific quality of the included studies used appropriately in 
formulating conclusions? 
(A) The results of the methodological rigor and scientific quality should be considered in the analysis and 
the conclusions of the review 
(B) The results of the methodological rigor and scientific quality are explicitly stated in formulating 
recommendations. 
(C) To have conclusions integrated/drives towards a clinical consensus statement 
(D) This clinical consensus statement drives toward revision or confirmation of clinical practice guidelines 
 
 
 
Yes 
 
No  
 
Yes 
No 
2 
 
 
Yes 
 
No  
 
Yes 
No 
2 
 
 
Yes 
 
No  
 
Yes 
No 
2 
 
 
Yes 
 
No  
 
Yes  
Yes  
3 
 
 
Yes 
 
No  
 
Yes 
No  
2 
 
 
Yes 
 
Yes  
 
Yes 
No  
3 
9. Were the methods used to combine the findings of studies appropriate? 
(A) Statement of criteria that were used to decide that the studies analysed were similar enough to be 
pooled? 
(B) For the pooled results, a test should be done to ensure the studies were combinable, to assess their 
homogeneity (i.e. Chi-squared test for homogeneity, I2). 
(C) Is there a recognition of heterogeneity or lack of thereof 
(D) If heterogeneity exists a “random effects model” should be used and/or the rationale (i.e. clinical 
appropriateness) of combining should be taken into consideration (i.e. is it sensible to combine?), or stated 
explicitly 
(E) If homogeneity exists, author should state a rationale or a statistical test 
 
 
Yes 
Yes  
 
Yes  
Yes 
 
Yes  
4 
 
Yes  
Yes  
 
Yes 
Yes 
 
Yes  
4  
 
No  
Yes  
 
Yes  
Yes 
 
NA 
3 
 
Yes 
Yes  
 
Yes  
Yes 
 
NA 
4 
 
Yes  
Yes  
 
Yes  
Yes 
 
Yes  
4 
 
Yes  
NA  
 
Yes  
NA 
 
NA 
2 
10. Was the likelihood of publication bias (a.k.a. “file drawer” effect) assessed? 
(A) Recognition of publication bias or file-drawer effect 
(B) An assessment of publication bias should include graphical aids (e.g., funnel plot, other available tests) 
(C) Statistical tests (e.g., Egger regression test). 
 
Yes 
Yes  
Yes  
 
Yes 
Yes  
Yes  
 
Yes 
Yes  
Yes 
 
Yes 
Yes  
Yes 
 
Yes 
Yes  
Yes  
 
Yes 
No  
No  
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 4 4 4 4 4 2 
11. Was the conflict of interest stated? 
(A) Statement of sources of support 
(B) No conflict of interest. This is subjective and may require some deduction or searching. 
(C) An awareness/statement of support or conflict of interest in the primary inclusion studies 
 
 
Yes  
Yes 
No  
3 
 
Yes  
Yes 
No  
3 
 
Yes  
Yes 
No 
3 
 
Yes  
Yes 
No 
3 
 
Yes  
Yes 
No  
3 
 
Yes  
Yes 
No 
3 
Total score (n/44) 
 
39 39 39 41 40 35 
a Studies were screened independently by two review authors. Data was extracted by one review author and checked by a second  
bWhile the authors didn’t explicitly state that they searched for reports regardless of publication type, it was clear from the included studies and/or text that a search of grey literature was conducted.   
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Table 4. Risk of bias of included RCTs 
Short title Review 
Reference 
 
Exercise for CHD  
Heran 2011 [10] 
Exercise for HF  
Taylor 2014a [8] 
Psychological for 
CHD Whalley 2011 
[11] 
Education for CHD 
Brown 2011 [12] 
Home vs centre  
Taylor 2014b [9] 
Uptake & adherence 
Karmali 2014 [13] 
Total 
aRandom sequence 
generation 
8 (17) 10 (30) 7 (29) 9 (69) 4 (24) 9 (50) 47 (31) 
aAllocation concealment 7 (15) 6 (18) 7 (29) 7(54) 7 (41) 8 (44) 41 (27) 
aGroups balanced at 
baseline 
b27 (57) 32 (97) b10 (42) 12(92) 14 (82) bc9(56) 103 (68) 
aOutcome blinding 4 (9) 11 (33) 5 (21) 4(31) 7 (41) 5 (28) 36 (24) 
aSelective reporting 0 (0) 31 (94) 16 (67) 12(92) 16 (94) 15 (83) 90 (59) 
aLoss to follow < 20% 33 (70) 29 (88) 13 (54) 10(77) 11 (65) 4 (22) 99 (65) 
aIntention to treat analysis b19 (40) 29 (88) 22(92) 11(85) 14 (82) bc7 (44) 101 (66) 
aGroups received same 
treatment apart from 
intervention* 
b21 (45) 21 (64) b16 (67) 11(85) 15 (88) bc15 (94) 100 (66) 
aN RCTs with low risk of bias (percent) 
bRisk of bias was not reported within the review, but was assessed by the authors of this overview 
cdenominator = 16 as two studies were unavailable to us as they were unpublished degree dissertations.  
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Table 5. Summary of outcome results across Cochrane systematic reviews 
Short title
 Revi
ew Reference 
 
Exercise for 
CHD  
Heran 2011 
[10] 
Exercise for HF  
Taylor 2014a 
[8] 
Psychological for 
CHD Whalley 2011 
[11] 
Education for CHD 
Brown 2011 [12] 
Home vs centre  
Taylor 2014b 
[9] 
Uptake & 
adherence 
Karmali 2014 
[13] 
Total mortality Follow up < 12 
months 
N=19 RCTs 
(6000 patients),  
RR = 0.82 [0.67 
to 1.01] 
I2 = 0% 
 
 
Follow up > 12 
months 
N=16 RCTs 
(5790 patients) 
RR = 0.87 (0.75 
to 0.99) 
I2= 0% 
Follow up < 12 
months 
N =25 RCTs ( 
1871 patients) 
RR = 0.93 
[0.697 to1.27] 
I2= 0% 
 
 
Follow up > 12 
months 
N=6 RCTs ( 
2845 patients) 
RR=0.88 [ 0.75 
to 1.02] 
I² = 34% 
 
N=17 RCTs (6852 
patients) 
RR = 0.89 [0.75 to 
1.05] 
I2=2% 
 
 
 
N = 6 RCTs  (2330 
patients)   
RR=0.79 [0.55 to 
1.13]  
I2 = 16% 
 
 
 
 
Follow up < 12 
months 
N =7 RCTs (1166 
patients) 
RR = 0.79 [0.43 
to 1.47] 
I2 = 0% 
 
 
Follow up > 12 
months 
N = 1 (525 
patients) 
RR = 1.99 [0.50 
to 7.88] 
 
 
N = 3 RCTs 
(211 patients) 
0/3 RCTs 
reported a 
significant 
difference 
between 
intervention 
and control 
groups  
(no pooling of 
data) 
 
Cardiovascular 
mortality 
 
Follow up < 12 
months 
N= 9 RCTs 
(4130 patients) 
RR = 0.93 [0.71 
to 1.21] 
I 2= 0.0% 
 
 
Follow-up > 12 
Months 
N = 12 RCTs 
(4757) 
RR = 0.74 [0.63 
to 0.87]  
I2 =  0.0% 
 
“Studies did not 
consistently 
report deaths 
due to heart 
failure or 
sudden death” 
 
N = 5 RCTs (3893 
patients) 
RR =  0.80 [0.6 to 
1.00] 
I2 = 0.0% 
 
 
 
 
NR NR NR 
Hospitalisation 
   
 
Follow up < 12 
months 
N = 4 RCTs (463 
patients) 
RR = 0.69 [0.51 
to 0.93] 
I2 = 12% 
 
 
Follow up >12 
months 
N = 7 RCTs 
(2009 patients) 
RR = 0.98 [0.87 
to 1.11] 
I2 = 56% 
Follow up < 12 
months 
N = 15 RCTs 
(1328 patients) 
RR = 0.75, [0.62 
to 0.92] 
I² = 0.0% 
 
 
Follow up > 12 
months 
N = 5 RCTs 
(2722) 
RR 0.92 [0.66 to 
1.29] 
I² = 63% 
NR At end of follow 
up period 
N = 4 RCTs (12905 
patients) 
RR = 0.83 [0.65 to 
1.07] 
I2 = 32% 
 
 
 
 
 
N = 1 RCT 
No difference 
between home 
and centre 
based CR  
 
 
N = 3 RCTs 
(numbers not 
provided) 
No significant 
difference 
between 
intervention 
and control 
groups  
(no pooling of 
data) 
 
Heart failure-
specific 
admissions  
 
NR Follow up > 12 
months 
N =12 RCTs 
(1036 patients) 
RR = 0.61 [0.46 
to 0.80] 
I² = 34% 
 
 
NR N = 1 RCT 
Patients in the 
intervention group 
had 41% fewer 
heart-related 
admissions (p = 
0.05) and 61% 
fewer Heart-
related inpatient 
days 
 (p=0.02) than in 
the control group.) 
NR NR 
Events 
MI 
    
 
Fatal and/or 
nonfatal MI  
Follow up < 12 
months 
NR Non-fatal MI  
 
N = 12 RCTs (7534 
patients) 
MI at the end of 
the follow up 
period 
N =2 RCTs (209 
 
 
N = 2 RCTs  
No difference 
CHD Event 
rates 
 
N = 3 RCTs 
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N = 12 RCTs 
(4216 patients) 
RR = 0.92 [0.70 
to 1.22] 
I² = 19% 
 
 
Follow up >12 
months 
N =16 RCTs 
(5682 patients) 
RR = 0.97 [0.82 
to 1.15] 
I² = 25% 
RR = 0.87 [0.67 to 
1.13]  
I2= 31% 
 
 
patients)  
RR = 0.63 [0.26 to 
1.48] 
I2 = 0% 
 
 
between home- 
and centre-
based CR (no 
pooling of data 
performed) 
 
(414 patients) 
2/3 RCTs 
reported no 
difference 
between 
intervention 
and control 
groups 
 
N = 1 (228 
patients) 
RR=1.66, p < 
0.01 
CABG 
 
Follow up < 12 
months 
 
N = 14 RCTs ( 
2312 patients) 
RR = 0.91 [0.67 
to 1.24]  
I2 = 0% 
 
 
Follow up > 12 
months 
N = 9 RCTs 
(2189 patients) 
RR = 0.93 [0.68 
to 1.27] 
I2 = 0% 
NR Revascularisation 
(CABG and PTCA 
combined) 
N = 12 RCTs (6670 
patients) 
RR  = 0.95 [0.80 to 
1.13] 
I2 = 13% 
 
 
At end of follow-
up period 
 
N =2 RCTs (209 
patients)  
RR = 0.58 [0.19 to 
1.71]  
I2= 0% 
 
 
 
Not reported by 
RCTs 
 
PTCA Follow up < 12 
months 
N =7 RCTs 
(1328 patients) 
RR = 1.02 [0.69 
to 1.50] 
I2 = 12% 
 
 
Follow up >12 
months 
N=6 RCTs (1322 
patients) 
RR= 0.89 [0.66 
to 1.19] 
I2=20% 
NR See above Not reported by 
RCTs 
Not reported by 
RCTs 
 
HRQL N = 10 
 
7/10 RCTs 
reported 
evidence of a 
significantly 
higher level of 
HRQL with 
intervention at 
follow-up. 
N = 20   
 
MLWHF score 
Follow up  < 12 
months 
N = 13 RCTs 
(1270 patients) 
WMD = -5.8 [-
9.2 to -2.4]  
I² = 70% 
 
Follow up  > 12 
months 
N = 3 RCTs (329 
patients) 
 
WMD = -9.5[-
17.54 to  -1.5] 
I² = 73% 
 
All HRQL 
measures 
pooled 
N = 20 RCTs  
N = 7 
 
1/7 RCTs reported 
evidence of a 
significantly higher 
level of HRQL with 
intervention at 
follow-up. 
Across 11 RCTs, 81 
HRQL outcome 
scores/subscores 
reported: 
 14/81 in favour 
of intervention 
compared to 
control 
 67/81 no 
significant 
difference 
between 
intervention 
and control 
 
5/11 RCTs 
reported evidence 
of a significantly 
higher level of 
some HRQL 
domains with 
intervention at 
follow-up.  
 
N = 10 
 
8/10 studies 
reported 
improvements 
in HRQL at 
follow-up with 
both home- and 
centre-based CR 
compared to 
baseline.  
 
No strong 
evidence of 
difference in 
overall HRQL 
outcomes or 
domain score at 
follow up 
between home- 
and centre-
based CR. 
 
N = 2  
 
1/2 studies 
reported 
improvement 
in HRQL with 
intervention 
(ns) 
 
1/2 studies 
reported 
improvement 
in both groups 
but no 
significant 
difference 
between 
intervention 
and control 
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(3240 patients) 
SMD = -0.5[ -
0.7 to -0.3] 
I² = 79% 
No consistent 
difference in HRQL 
total or domain 
score at follow-up 
between 
intervention and 
control 
Economics 
   Costs 
 
 
 
 
 
   Cost-
effectiveness 
Costs 
2/3 studies 
reported total 
healthcare 
costs was not 
statistically 
significantly 
different 
between 
groups. 
 
Cost-
effectiveness 
N = 1 
Authors 
concluded that 
rehabilitation 
was an efficient 
use of health-
care resources 
and may be 
economically 
justified 
  
N = 3 
Two studies 
undertook  a 
cost 
effectiveness 
analysis and 
one reported 
costs  
There was no 
evidence of 
significantly 
different costs 
or outcomes 
 
NR N = 5 RCTs 
reported 
healthcare 
utilisation costs.  
 
2/5 RCTs reported 
an overall average 
net saving 
of US$965 per 
patient at 6 
months follow up  
and US$1420 per 
patient at 24 
months follow up.  
 
1/5 reported an 
increase in 
average net costs 
of US$52 per 
patient 
 
2/5 reported no 
difference 
between groups 
 
No RCTs reported 
cost-effectiveness 
3/4 RCTs 
reported 
healthcare costs 
associated with 
CR were lower 
for the home-
based than 
centre-based 
programmes 
 
1/4 reported 
that home-
based CR was 
more costly 
than centre-
based CR but 
costs would be 
the same if 
patient costs 
were included.  
8 studies 
reported 
different 
aspects of 
consumption of 
healthcare 
resources.  
 
No significant 
between group 
differences 
were seen. 
NR 
All cause 
withdrawal 
/drop out at 
follow-up 
NR NR NR At follow-up 
N = 8 RCTs (2862 
patients) 
RR = 1.03 [0.83 to 
1.27]  
I2 = 34% 
 
At follow-up 
N = 18 (1894 
patients)  
RR = 1.04 [1.00 
to 1.08]  
I² = 44% 
NR 
Uptake NR NR NR NR NR N = 10 (1,338 
patients) 
8/10 studies 
reported 
uptake was 
significantly 
higher in 
intervention 
group 
Adherence NR NR NR NR N = 14  
a3/14 studies 
reported 
adherence was 
significantly 
higher in home-
based CR 
N = 8 (1,150 
patients) 
3/8 studies 
reported 
adherence was 
significantly 
higher in 
intervention 
group 
NR = Not reported 
ns = not significant 
a
As reported in the Summary of Findings table. Effects of interventions section states 4/1Appendices 
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Appendix A: Search Strategy 
The Cochrane Library 
#1 cardiac near/4 rehab* 
#2 cardiac near/4 exercise* 
#1 OR #2 
 
Appendix B: Protocols identified 
Author Year  Title 
Devi   2011 Internet based interventions for the secondary prevention of 
coronary heart disease 
Euler  2013 Interventions to support return-to-work for patients with coronary 
heart disease 
Sibilitz 
 
2013 
 
Exercise-based cardiac rehabilitation for adults after heart valve 
surgery  
Rissom 
 
2014 Exercise-based cardiac rehabilitation for adultswith atrial 
fibrillation 
*Mechta-
Nielsen 
 Exercise-based cardiac rehabilitation for adult patients with ICD 
*We are aware of this proposed title through Personal Communication with the authors 
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Figure 1 PRISMA Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
Records identified through 
database searching 
(n = 91) 
Id
e
n
ti
fi
c
a
ti
o
n
 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 91 ) 
Records screened 
(n = 10) 
Protocols identified for 
future update of overview 
(n = 3) 
S
c
re
e
n
in
g
 
In
c
lu
d
e
d
 
E
li
g
ib
il
it
y
 Full-text articles assessed 
for eligibility 
(n = 7) 
Full-text articles excluded, 
with reasons 
(n =  1) 
Studies included in 
qualitative synthesis 
(n = 6 ) 
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